Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Iovance Biotherapeutics
Iovance Biotherapeutics is a leading US biopharmaceutical company dedicated to the development and commercialization of innovative cell therapies for cancer patients. It is transforming cancer treatment through its unique tumor-infiltrating lymphocyte (TIL) therapy within the field of cancer immunotherapy, offering new hope for those affected.
Frequently asked questions
When will Iovance Biotherapeutics report its next quarterly earnings?
Iovance Biotherapeutics is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Iovance Biotherapeutics last report quarterly earnings?
Iovance Biotherapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.11 USD.
How does Iovance Biotherapeutics stock react to earnings?
Across its last 3 earnings reports, Iovance Biotherapeutics stock moved by ±14.9% on average the following day. The largest reaction was +30.8% on 02/24/2026; 1 of 3 reactions were positive.
How often has Iovance Biotherapeutics beaten expectations?
Iovance Biotherapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Iovance Biotherapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±14.9%
Avg. next-day move
+30.8%
Largest move (02/24/2026)
33.3%
Share of positive reactions
±27.8%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
-1.8%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Iovance Biotherapeutics
Country
🇺🇸
More Financial Information